IL10 and neoplasm: Thus collectively, even under the detrimental influences of tumor microenvironment, NLGP initiates an inflammation-favoring anticancer type 1 immune-commitment through upregulation of pro-inflammatory IL-12p70 and reduction of anti-inflammatory IL-10 secretion from murine dendritic cells.